Razelle Kurzrock: Rare and ultra-rare cancers – large unmet need
Razelle Kurzrock shared a post on X:
”Rare and ultra-rare cancers are large unmet need. Personalized N-of-1 approach via Molecular Tumor Board UCSD. Higher degrees of molecular matching, leading to improved outcomes.”
Read further.
Source: Razelle Kurzrock/X
Razelle Kurzrock serves as the Associate Director of Clinical Research at the Medical College of Wisconsin Cancer Center, and also holds the position of Associate Director of Precision Oncology at the Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine. Additionally, Dr. Kurzrock is the founding director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center. Renowned as one of the world’s top 25 voices in precision medicine, she is celebrated for her contributions, of having over 950 scientific and medical publications. Dr. Kurzrock’s work continues to shape the landscape of oncology, driving innovation and breakthroughs in cancer treatment and research.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023